)
MedPlus Health Services (MEDPLUS) investor relations material
MedPlus Health Services Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Added 145 new stores in Q2 FY26, with a net addition of 117 stores after closures; network now at 4,930 stores across 13 states and 1 union territory, covering over 2.6 million sq ft.
Achieved consolidated revenue of ₹16,793 million in Q2 FY26, up 6.5% year-over-year and 8.9% sequentially; net profit (PAT) rose 43.4% YoY to ₹555 million.
Private label sales constitute 21.5% of total revenue; pharma at 12.1% and non-pharma at 9.6%.
Diagnostic revenue grew to ₹332.5 million, with operating EBITDA margin for diagnostics improving to 15.3%.
Board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, with no material misstatements in auditor review.
Financial highlights
Consolidated revenue for Q2 FY26 was ₹16,793 million, up from ₹15,761.72 million in Q2 FY25; H1FY26 revenue reached ₹32,220 million.
Consolidated operating EBITDA stood at ₹887 million (5.3% margin), up 20% YoY; pharmacy operating EBITDA at ₹839 million (5.1% margin).
Gross margin improved to 26.1%, up 240 bps YoY; PAT margin for Q2FY26 was 3.3%.
Pharmacy revenue grew 8.8% YoY (GMV basis) and 6.3% YoY (net basis); store-level EBITDA margin for stores >12 months: 11.8%.
Operating cash flow for Q2FY26 was ₹1,261 million, with a closing cash and bank balance of ₹6,085 million.
Outlook and guidance
Targeting 600 new store additions in FY26; confident in meeting franchisee store addition targets.
SSSG (same-store sales growth) turned positive at 2.2% in Q2; expected to reach high single digits (9-10%) over the next two years.
Focus on increasing private label contribution in both pharma and FMCG categories for higher margins.
No immediate expansion in diagnostics until subscription numbers increase; current CapEx model on hold.
Management and auditors confirm compliance with accounting standards and regulatory requirements.
Next MedPlus Health Services earnings date
Next MedPlus Health Services earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)